Welbourn Richard, Pournaras Dimitri J, Dixon John, Higa Kelvin, Kinsman Robin, Ottosson Johan, Ramos Almino, van Wagensveld Bart, Walton Peter, Weiner Rudolf, Zundel Natan
Department Upper GI and Bariatric Surgery, Musgrove Park Hospital, Taunton, TA1 5DA, UK.
Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Obes Surg. 2018 Feb;28(2):313-322. doi: 10.1007/s11695-017-2845-9.
Five International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) surveys since 1998 have estimated the volume and type of bariatric surgery being done in constituent member countries. These reports did not include baseline demographic descriptions.
An IFSO Global Registry pilot project in 2014 demonstrated that it was possible to amalgamate large numbers of individual patient data from different local and national database systems. Here we describe demographic data from the second report for 54,490 patients from 31 countries operated in the 3 calendar years 2013-2015 and follow up data from 66,560 of 112,544 patients in 2009-2015.
Most procedures (97.8%) were performed laparoscopically and 73.3% (95% CI: 73.0-73.7%, range 54.2 to 80.3%) were female. The average age was 42.0 years (95% CI 41.9-42.1, inter-quartile range 33.0-51.0 years) and the median body mass index was 43.3 kg/m (inter-quartile range 39.4-48.8 kg/m). Before surgery, 22.0% patients had type 2 diabetes (inter-country variation 7.4-63.2%); 31.9% were hypertensive (15.8-92.7%); 17.6% had depression (0.0-46.3%); 27.8% took medication for musculoskeletal pain (0.0-58.9%); 18.9% had sleep apnea (0.0-63.2%); and 29.6% of patients had gastro-esophageal reflux disease (9.1-90.9%). Gastric bypass was the most prevalent operation (49.4%), followed by sleeve gastrectomy (40.7%) and gastric banding (5.5%). The 1-year total weight loss for patients with available data was 30.53% (95% CI: 30.22-30.84%) and in the cohort 2009-15 was 30.4% with a follow-up rate of 59.14%. In the 2009-2015 cohort, 64.7% of patients on treatment for diabetes preoperatively were not on treatment postoperatively.
There is widespread variation in access to surgery and in baseline patient characteristics in the countries submitting data to the IFSO Global Registry.
自1998年以来,国际肥胖与代谢病外科联盟(IFSO)开展的五项调查估计了其成员国进行的减肥手术的数量和类型。这些报告未包括基线人口统计学描述。
2014年IFSO全球注册试点项目表明,可以整合来自不同地方和国家数据库系统的大量个体患者数据。在此,我们描述了2013 - 2015这三个日历年中31个国家的54490例接受手术患者的第二份报告中的人口统计学数据,以及2009 - 2015年112544例患者中66560例患者的随访数据。
大多数手术(97.8%)通过腹腔镜进行,73.3%(95%可信区间:73.0 - 73.7%,范围54.2至80.3%)为女性。平均年龄为42.0岁(95%可信区间41.9 - 42.1,四分位间距33.0 - 51.0岁),体重指数中位数为43.3kg/m²(四分位间距39.4 - 48.8kg/m²)。手术前,22.0%的患者患有2型糖尿病(国家间差异7.4 - 63.2%);31.9%患有高血压(15.8 - 92.7%);17.6%患有抑郁症(0.0 - 46.3%);27.8%服用治疗肌肉骨骼疼痛的药物(0.0 - 58.9%);18.9%患有睡眠呼吸暂停(0.0 - 63.2%);29.6%的患者患有胃食管反流病(9.1 - 90.9%)。胃旁路手术是最常见的手术(49.4%),其次是袖状胃切除术(40.7%)和胃束带术(5.5%)。有可用数据的患者1年总体重减轻为30.53%(95%可信区间:30.22 - 30.84%),2009 - 15年队列中的总体重减轻为30.4%,随访率为59.14%。在2009 - 2015年队列中,术前接受糖尿病治疗的患者中有64.7%术后不再接受治疗。
向IFSO全球注册提交数据的国家在手术可及性和患者基线特征方面存在广泛差异。